Research Reagents for SARS-CoV-2 Omicron Variant : vimarsana

Sino Biological, Inc. (https://www.sinobiological.com; SHE: 301047) announced today that it has launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-CoV-2 virus

Related Keywords

China , Beijing , Shenzhen , Guangdong , Jie Zhang , Shenzhen Stock Exchange , Sino Biological Inc , Sino Biological Inc Dec , From Sino Biological Inc Dec , Sino Biological , Omicron Spike , Private Securities Litigation Reform , Shenzhen Stock , Reagents , Research , Cars , Ars Cov 2 , Antibodies , Ntibody , Ntigen , Essay , Pandemic , Protein , Pseudovirus , Spike Protein , Virus ,